Nicotine replacement therapy combination

2 marketed

This page covers all Nicotine replacement therapy combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Nicotinic acetylcholine receptors, Mu-opioid receptor (naltrexone); nicotinic acetylcholine receptors (nicotine).

Targets

Nicotinic acetylcholine receptors · Mu-opioid receptor (naltrexone); nicotinic acetylcholine receptors (nicotine)

Marketed (2)

Patent intelligence